134 related articles for article (PubMed ID: 31655941)
1. Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.
Suppanuntaroek S; Hatakeyama S; Fujita N; Kubota Y; Suzuki Y; Okamoto T; Tobisawa Y; Yoneyama T; Yamamoto H; Mori K; Imai A; Yoneyama T; Hashimoto Y; Ohyama C
Int J Clin Oncol; 2020 Feb; 25(2):362-369. PubMed ID: 31655941
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Kido K; Hatakeyama S; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
Int J Clin Oncol; 2018 Aug; 23(4):726-733. PubMed ID: 29435873
[TBL] [Abstract][Full Text] [Related]
4. A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.
Altan M; Haberal HB; Akdoğan B; Özen H
Int J Clin Oncol; 2017 Oct; 22(5):964-971. PubMed ID: 28600686
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy.
Ku JH; Kang M; Kim HS; Jeong CW; Kwak C; Kim HH
Br J Cancer; 2015 Feb; 112(3):461-7. PubMed ID: 25584490
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence.
Li Q; Assel M; Benfante N; Pietzak E; Bagrodia A; Cha E; Dalbagni G; Coleman J
J Urol; 2017 Sep; 198(3):546-551. PubMed ID: 28342936
[TBL] [Abstract][Full Text] [Related]
8. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.
Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF
J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer].
Miyanaga N; Akaza H; Shinohara N; Koyanagi T; Tsujino S; Miki M; Tobisu K; Niimi M; Hinotsu J
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):445-53. PubMed ID: 10349303
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
11. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Urol Oncol; 2017 Sep; 35(9):539.e9-539.e16. PubMed ID: 28499734
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer.
Daly L; Dolan R; Power D; Ní Bhuachalla É; Sim W; Fallon M; Cushen S; Simmons C; McMillan DC; Laird BJ; Ryan A
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):160-168. PubMed ID: 31692296
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.
Luoma ML; Hakamies-Blomqvist L; Sjöström J; Pluzanska A; Ottoson S; Mouridsen H; Bengtsson NO; Bergh J; Malmström P; Valvere V; Tennvall L; Blomqvist C
Eur J Cancer; 2003 Jul; 39(10):1370-6. PubMed ID: 12826039
[TBL] [Abstract][Full Text] [Related]
14. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Cho DS; Kim SI; Ahn HS; Kim SJ
Urol Int; 2013; 91(2):153-9. PubMed ID: 23391941
[TBL] [Abstract][Full Text] [Related]
16. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Necchi A; Sonpavde G; Lo Vullo S; Giardiello D; Bamias A; Crabb SJ; Harshman LC; Bellmunt J; De Giorgi U; Sternberg CN; Cerbone L; Ladoire S; Wong YN; Yu EY; Chowdhury S; Niegisch G; Srinivas S; Vaishampayan UN; Pal SK; Agarwal N; Alva A; Baniel J; Golshayan AR; Morales-Barrera R; Bowles DW; Milowsky MI; Theodore C; Berthold DR; Daugaard G; Sridhar SS; Powles T; Rosenberg JE; Galsky MD; Mariani L;
Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma.
Hsieh MC; Sung MT; Chiang PH; Huang CH; Tang Y; Su YL
PLoS One; 2015; 10(6):e0129268. PubMed ID: 26114748
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base.
Seisen T; Sun M; Leow JJ; Preston MA; Cole AP; Gelpi-Hammerschmidt F; Hanna N; Meyer CP; Kibel AS; Lipsitz SR; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
J Clin Oncol; 2016 Oct; 34(29):3529-3536. PubMed ID: 27269944
[TBL] [Abstract][Full Text] [Related]
19. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery.
Urakami S; Yuasa T; Yamamoto S; Sakura M; Tanaka H; Hayashi T; Uehara S; Inoue Y; Fujii Y; Masuda H; Fukui I; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1171-8. PubMed ID: 25953680
[TBL] [Abstract][Full Text] [Related]
20. Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Sakano S; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Kaneda Y; Nasu T; Hashimoto O; Joko K; Baba Y; Shimabukuro T; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Matsumura M;
Ann Surg Oncol; 2013 Dec; 20(13):4389-96. PubMed ID: 24046115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
